本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Profound Medical Corp.

5.98
-0.1150-1.89%
盘后5.980.0050+0.08%15:19 EDT
成交量:1.04万
成交额:6.22万
市值:1.80亿
市盈率:-4.90
高:6.06
开:6.06
低:5.93
收:6.09
数据加载中...
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/15

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/07

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/03

年度报告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/03

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]